This effect was larger in the RA group , where bivalirudin significantly reduced periprocedural MI ( 15.7 % vs. 38.7 % , p = 0.01 ) with a trend towards reduced major ASB ( 2.9 % vs. 10.2 % , p = 0.09 ) .